Neogenomics, Inc.
NEO
$10.10
-$0.44-4.18%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 386.84M | 387.81M | 387.86M | 384.83M | 415.20M |
Total Receivables | 150.64M | 152.83M | 148.08M | 142.12M | 131.26M |
Inventory | 26.75M | 24.46M | 23.21M | 20.32M | 24.16M |
Prepaid Expenses | 20.17M | 18.24M | 17.40M | 19.16M | 17.99M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 11.62M | 6.91M | 7.66M | 7.48M | 8.20M |
Total Current Assets | 596.02M | 590.24M | 584.20M | 573.90M | 596.81M |
|
|||||
Total Current Assets | 596.02M | 590.24M | 584.20M | 573.90M | 596.81M |
Net Property, Plant & Equipment | 173.69M | 174.48M | 175.83M | 174.44M | 183.78M |
Long-term Investments | 522.77M | 522.77M | 522.77M | 522.77M | 522.77M |
Goodwill | 522.77M | 522.77M | 522.77M | 522.77M | 522.77M |
Total Other Intangibles | 339.68M | 348.04M | 356.40M | 364.76M | 373.13M |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 5.89M | 5.58M | 4.08M | 4.47M | 4.74M |
Total Assets | 1.64B | 1.64B | 1.64B | 1.64B | 1.68B |
|
|||||
Total Accounts Payable | 21.61M | 16.51M | 17.19M | 18.34M | 20.33M |
Total Accrued Expenses | 75.07M | 75.16M | 68.15M | 52.74M | 68.23M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 204.16M | 204.14M | 203.65M | 4.49M | 5.61M |
Total Finance Division Other Current Liabilities | 409.00K | 589.00K | 972.00K | 1.14M | 2.13M |
Total Other Current Liabilities | 409.00K | 589.00K | 972.00K | 1.14M | 2.13M |
Total Current Liabilities | 301.24M | 296.41M | 289.96M | 76.71M | 96.30M |
|
|||||
Total Current Liabilities | 301.24M | 296.41M | 289.96M | 76.71M | 96.30M |
Long-Term Debt | 340.34M | 339.96M | 339.58M | 538.92M | 538.20M |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 60.84M | 62.17M | 63.29M | 64.77M | 67.87M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 33.28M | 34.37M | 34.56M | 36.52M | 37.32M |
Total Liabilities | 735.70M | 732.90M | 727.39M | 716.93M | 739.69M |
|
|||||
Common Stock & APIC | 1.23B | 1.22B | 1.21B | 1.20B | 1.19B |
Retained Earnings | -325.78M | -310.46M | -292.76M | -274.12M | -247.06M |
Treasury Stock & Other | -206.00K | -643.00K | -1.02M | -1.33M | -1.67M |
Total Common Equity | 902.34M | 908.21M | 915.88M | 923.41M | 941.54M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 902.34M | 908.21M | 915.88M | 923.41M | 941.54M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 902.34M | 908.21M | 915.88M | 923.41M | 941.54M |
|